v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Operating activities          
Net income $ 74,430 $ 59,053 $ 118,708 $ 85,531  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and finance lease amortization     43,292 35,241  
Amortization of intangible assets 25,681 24,791 51,170 49,541  
Amortization of deferred financing costs and original issue discount     1,278 1,948  
Change in fair value of investments 1,524 2,117 11,471 8,136  
Deferred income taxes     (18,668) (18,140)  
Share-based compensation expense [1] 14,752 12,715 26,360 25,155  
Loss (gain) on disposal of assets     602 (28)  
Loss attributable to the disposition of a business     3,905 0  
Other noncash charges     1,513 1,680  
Excess tax expense (benefits) from equity awards     90 (602)  
Net changes in operating assets and liabilities:          
Accounts receivable     (485) (74,467)  
Inventories     (199,279) 12,245  
Other assets     7,990 12,881  
Accounts payable     129,489 73,994  
Accrued wages and employee benefits     (28,297) 5,679  
Other accrued liabilities     (18,798) (29,232)  
Net cash provided by operating activities     130,341 189,562  
Investing activities          
Proceeds from sale of property and equipment     0 85  
Contribution to tax equity investment     0 (1,629)  
Purchase of long-term investments     (2,656) (1,896)  
Proceeds from sale of long-term investments     0 2,000  
Expenditures for property and equipment (57,716) (27,952) (88,653) (54,772)  
Acquisition of business, net of cash acquired     0 (17,812)  
Other investing activities     (1,999) 0  
Net cash used in investing activities     (93,308) (74,024)  
Financing activities          
Proceeds from short-term borrowings     21,860 20,728  
Proceeds from long-term borrowings     92,585 2,881  
Repayments of short-term borrowings     (30,171) (39,011)  
Repayments of long-term borrowings and finance lease obligations     (29,032) (14,657)  
Stock repurchases     (147,917) (50,609)  
Payment of deferred acquisition consideration     0 (7,361)  
Cash dividends paid to noncontrolling interest of subsidiary     (293) 0  
Purchase of additional ownership interest     0 (9,117)  
Taxes paid related to equity awards     (9,393) (9,983)  
Proceeds from the exercise of stock options     1,043 10,620  
Net cash used in financing activities     (101,318) (96,509)  
Effect of foreign exchange rate changes on cash and cash equivalents     6,539 (1,706)  
Net (decrease) increase in cash and cash equivalents     (57,746) 17,323  
Cash and cash equivalents at beginning of period     281,277 200,994 $ 200,994
Cash and cash equivalents at end of period $ 223,531 $ 218,317 $ 223,531 $ 218,317 $ 281,277
[1] Represents share-based compensation expense to account for stock options, restricted stock, and other stock awards over their respective vesting periods.